HB 1333 would expand New Hampshire’s criminal homicide laws in two related ways. First, it creates a first-degree murder theory for a person who gives a pregnant woman medication intended to end a pregnancy without her knowledge or consent. Second, it broadens the state’s fetal homicide definition so that a fetus is protected from conception, or from implantation in the case of in vitro fertilization, rather than only after the twentieth week of pregnancy.
The bill amends RSA 630:1-a, the state’s first-degree murder and fetal homicide statute, by adding nonconsensual administration of abortion-inducing medication as a qualifying act and by revising the definition of “fetus.” If enacted, it would make the homicide statute apply earlier in pregnancy and in IVF-related pregnancies, potentially affecting criminal investigations, prosecutions, and sentencing in cases involving pregnancy loss caused by unlawful conduct. The bill is scheduled to take effect January 1, 2027.
The fiscal note says the bill would not change state or local revenue, but could create indeterminable costs for the judicial and correctional systems because it adds or modifies a criminal penalty. Those costs could include prosecution, incarceration, probation, and parole expenses for the state and for counties and municipalities.
No committee transcript or recorded vote information was provided, so there is no direct evidence of debate or floor sentiment in the materials supplied. Based on the bill’s subject matter, the measure appears to be framed as a criminal justice and fetal-protection bill, and its impact would likely be felt most by prosecutors, courts, corrections officials, pregnant patients, and providers or others involved in medication abortion or pregnancy-related conduct.
The main point of contention is likely the bill’s expansion of homicide liability to earlier stages of pregnancy and to IVF implantation, as well as the creation of a first-degree murder charge for nonconsensual provision of abortion medication. Supporters would likely view it as strengthening protections against covert or coerced pregnancy termination, while opponents may argue it broadens criminal liability in a highly sensitive area of reproductive health and could raise legal and medical concerns.
HB 1333 would amend RSA 630:1-a to expand first-degree murder and fetal homicide provisions. It would add a new first-degree murder circumstance for administering medication intended to terminate a pregnancy without the pregnant woman’s knowledge or consent, and it would redefine “fetus” to begin at conception, or at implantation for IVF pregnancies, instead of at the twentieth week. This would likely broaden the reach of New Hampshire’s homicide laws and could affect criminal investigations, charging decisions, and sentencing in pregnancy-related cases.
No committee testimony or vote record was provided, so the materials do not show an official recorded sentiment. The bill’s framing suggests a protective, punitive approach toward nonconsensual abortion medication and fetal harm, which would likely draw support from advocates for fetal protection and opposition from reproductive rights advocates and some medical stakeholders. The fiscal note is neutral on policy but anticipates possible judicial and correctional costs.
The central controversy is the bill’s expansion of criminal liability to conduct involving pregnancy termination medication and its move to define fetal homicide from conception or implantation rather than from 20 weeks. Supporters are likely to emphasize protection against covert or coerced abortion and stronger accountability for harmful conduct. Opponents are likely to focus on the breadth of the homicide expansion, possible effects on reproductive healthcare and IVF, and the legal and medical implications of treating earlier pregnancy stages as homicide victims.